| Dr Barry Jay Landau, MD | |
|
710 Birchwood Ave, Suite 101, Bellingham, WA 98225-1720 | |
| (360) 676-0922 | |
| (360) 671-4726 |
| Full Name | Dr Barry Jay Landau |
|---|---|
| Gender | Male |
| Speciality | Neurosurgery |
| Experience | 36 Years |
| Location | 710 Birchwood Ave, Bellingham, Washington |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053382671 | NPI | - | NPPES |
| 8278863 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207T00000X | Neurological Surgery | MD00039977 (Washington) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Joseph Hospital | Bellingham, WA | Hospital |
| Island Hospital | Anacortes, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Fourth Corner Neurosurgical Associates Inc Ps | 1557250248 | 8 |
News Archive
The U.S. Food and Drug Administration today approved Afrezza (insulin human) Inhalation Powder, a rapid-acting inhaled insulin to improve glycemic control in adults with diabetes mellitus. Afrezza is a rapid-acting inhaled insulin that is administered at the beginning of each meal, or within 20 minutes after starting a meal.
The amount of added sugar in the American diet has increased dramatically over the last 50 years. Much of that increase comes from higher intake of sugar-sweetened beverages, which constitute approximately one-third of the total added sugar consumption in the American diet.
For physicians treating patients with diabetes, practical support is important in improving glycemic control. Researchers writing in the open access journal BMC Public Health found that setting goals and pro-active follow-up helped patients achieve good glycemic control.
This week, at the second Global Consultation on Transplantation the World Health Organization (WHO) presented countries and other stakeholders with a blueprint for updated global guiding principles on cell, tissue and organ donation and transplantation.
› Verified 8 days ago
| Entity Name | Public Hospital Dist No 1 Skagit |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023332749 PECOS PAC ID: 6800793522 Enrollment ID: O20040309001059 |
News Archive
The U.S. Food and Drug Administration today approved Afrezza (insulin human) Inhalation Powder, a rapid-acting inhaled insulin to improve glycemic control in adults with diabetes mellitus. Afrezza is a rapid-acting inhaled insulin that is administered at the beginning of each meal, or within 20 minutes after starting a meal.
The amount of added sugar in the American diet has increased dramatically over the last 50 years. Much of that increase comes from higher intake of sugar-sweetened beverages, which constitute approximately one-third of the total added sugar consumption in the American diet.
For physicians treating patients with diabetes, practical support is important in improving glycemic control. Researchers writing in the open access journal BMC Public Health found that setting goals and pro-active follow-up helped patients achieve good glycemic control.
This week, at the second Global Consultation on Transplantation the World Health Organization (WHO) presented countries and other stakeholders with a blueprint for updated global guiding principles on cell, tissue and organ donation and transplantation.
› Verified 8 days ago
| Entity Name | Fourth Corner Neurosurgical Associates Inc Ps |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699846386 PECOS PAC ID: 1557250248 Enrollment ID: O20040311000840 |
News Archive
The U.S. Food and Drug Administration today approved Afrezza (insulin human) Inhalation Powder, a rapid-acting inhaled insulin to improve glycemic control in adults with diabetes mellitus. Afrezza is a rapid-acting inhaled insulin that is administered at the beginning of each meal, or within 20 minutes after starting a meal.
The amount of added sugar in the American diet has increased dramatically over the last 50 years. Much of that increase comes from higher intake of sugar-sweetened beverages, which constitute approximately one-third of the total added sugar consumption in the American diet.
For physicians treating patients with diabetes, practical support is important in improving glycemic control. Researchers writing in the open access journal BMC Public Health found that setting goals and pro-active follow-up helped patients achieve good glycemic control.
This week, at the second Global Consultation on Transplantation the World Health Organization (WHO) presented countries and other stakeholders with a blueprint for updated global guiding principles on cell, tissue and organ donation and transplantation.
› Verified 8 days ago
| Entity Name | Fourth Corner Neurosurgical Associates Inc Ps |
|---|---|
| Entity Type | Part B Supplier - Ambulatory Surgical Center |
| Entity Identifiers | NPI Number: 1275938102 PECOS PAC ID: 1557250248 Enrollment ID: O20160706002786 |
News Archive
The U.S. Food and Drug Administration today approved Afrezza (insulin human) Inhalation Powder, a rapid-acting inhaled insulin to improve glycemic control in adults with diabetes mellitus. Afrezza is a rapid-acting inhaled insulin that is administered at the beginning of each meal, or within 20 minutes after starting a meal.
The amount of added sugar in the American diet has increased dramatically over the last 50 years. Much of that increase comes from higher intake of sugar-sweetened beverages, which constitute approximately one-third of the total added sugar consumption in the American diet.
For physicians treating patients with diabetes, practical support is important in improving glycemic control. Researchers writing in the open access journal BMC Public Health found that setting goals and pro-active follow-up helped patients achieve good glycemic control.
This week, at the second Global Consultation on Transplantation the World Health Organization (WHO) presented countries and other stakeholders with a blueprint for updated global guiding principles on cell, tissue and organ donation and transplantation.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Barry Jay Landau, MD 710 Birchwood Ave, Suite 101, Bellingham, WA 98225-1720 Ph: (360) 676-0922 | Dr Barry Jay Landau, MD 710 Birchwood Ave, Suite 101, Bellingham, WA 98225-1720 Ph: (360) 676-0922 |
News Archive
The U.S. Food and Drug Administration today approved Afrezza (insulin human) Inhalation Powder, a rapid-acting inhaled insulin to improve glycemic control in adults with diabetes mellitus. Afrezza is a rapid-acting inhaled insulin that is administered at the beginning of each meal, or within 20 minutes after starting a meal.
The amount of added sugar in the American diet has increased dramatically over the last 50 years. Much of that increase comes from higher intake of sugar-sweetened beverages, which constitute approximately one-third of the total added sugar consumption in the American diet.
For physicians treating patients with diabetes, practical support is important in improving glycemic control. Researchers writing in the open access journal BMC Public Health found that setting goals and pro-active follow-up helped patients achieve good glycemic control.
This week, at the second Global Consultation on Transplantation the World Health Organization (WHO) presented countries and other stakeholders with a blueprint for updated global guiding principles on cell, tissue and organ donation and transplantation.
› Verified 8 days ago
Mr. Michael Scott Lawrence, MD Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 710 Birchwood Ave, Suite 101, Bellingham, WA 98225 Phone: 360-676-0922 Fax: 360-671-4726 | |
Dr. Marc Joseph Billings, DO Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 710 Birchwood Ave Ste 101, Bellingham, WA 98225 Phone: 360-676-0922 Fax: 360-647-4726 | |
Ramana Gorrepati, Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 710 Birchwood Ave Ste 101, Bellingham, WA 98225 Phone: 360-676-0922 Fax: 360-671-4726 | |
Dr. David Edward Baker, MD Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 710 Birchwood Ave, Suite 101, Bellingham, WA 98225 Phone: 360-676-0922 Fax: 360-671-4726 | |
Tung Mai Ha, DO Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 710 Birchwood Ave, Ste 101, Bellingham, WA 98225 Phone: 360-676-0922 Fax: 360-671-4726 | |
Mr. David L. Goldman, MD Neurological Surgery Medicare: Medicare Enrolled Practice Location: 710 Birchwood Ave, #101, Bellingham, WA 98225 Phone: 360-676-0922 Fax: 360-671-4726 |